Showing results (401-410 of 538) with videos related to
Sort By:
Pageof 54
Plos One|August 28, 2015
Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR CohortGaetane Nocturne, Stephan Pavy, Saida Boudaoud, et al.Annals of the Rheumatic Diseases|June 9, 2012
The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasoundMaxime Dougados, Valérie Devauchelle-Pensec, Jean François Ferlet, et al.Rheumatology (Oxford, England)|October 16, 2020
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)Anna Molto, Laure Gossec, Serge Poiraudeau, et al.Annals of the Rheumatic Diseases|December 15, 2016
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndromeBenjamin A Fisher, Roland Jonsson, Troy Daniels, et al.Human Molecular Genetics|April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICARaphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.JAMA Network Open|July 12, 2023
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug AntibodiesSamuel Bitoun, Signe Hässler, David Ternant, et al.Rheumatology (Oxford, England)|September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndromeMaria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.Annals of Internal Medicine|April 15, 2014
Treatment of primary Sjögren syndrome with rituximab: a randomized trialValérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, et al.Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.RMD Open|July 6, 2019
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patientsLaure Gossec, Martin Soubrier, Frantz Foissac, et al.Pageof 54